Article ID Journal Published Year Pages File Type
3869067 The Journal of Urology 2011 6 Pages PDF
Abstract
Men with an undetectable prostate specific antigen for more than 10 years have a low risk of subsequent biochemical recurrence, with correspondingly lower rates of metastasis and death. These patients should be counseled that their risk of subsequent cancer related morbidity and mortality is low. Furthermore, these results suggest that annual prostate specific antigen testing may be safely discontinued after 10 years for men with a prostatectomy Gleason score 6 or less and/or limited life expectancy.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , , , ,